Sommaire

• • ·Can we control dengue?

    Page :1095

     
• • ·The therapeutic validation of long COVID

    Page :1096-1097

    Jeremy Samuel Faust

     
• • ·Safety of COVID-19 booster dose: is the juice worth the squeeze?

    Page :1097-1099

    Shabir A Madhi, Alane Izu

     
• • ·Exploring the potential benefits of mucosal COVID-19 vaccines: opportunities and challenges

    Page :1099-1100

    Julio Croda

     
• • ·Tafenoquine and artemisinin-based combination therapy for vivax malaria: end of the road or just the beginning?

    Page :1100-1102

    Kamala Thriemer, Robert J Commons

     
• • ·Moving seasonal malaria chemoprevention out of its geographical isolation

    Page :1102-1103

    Ally Olotu, Jörg J Möhrle

     
• • ·Inactivated Zika virus vaccine and the complexity of flavivirus antigenicity

    Page :1103-1105

    Jenny G Low, Eng Eong Ooi

     
• • ·VLA15, a new global Lyme disease vaccine undergoes clinical trials

    Page :1105-1106

    Ondrej Hajdusek, Jan Perner

     
• • ·Haemophilus influenzae is fighting back: is serotype a an emerging threat?

    Page :1106-1108

    Emma C Wall, Muhamed-Keir Taha

     
• • ·COVID-19 pandemic: a catalyst for accelerating global action on patient safety

    Page :1108-1110

    Rebecca Grant, Daniel Benamouzig, Howard Catton, Vincent Chi-Chung Cheng, Neelam Dhingra, Ramanan Laxminarayan, Helena Legido-Quigley, Susanna Lorenzo Martinez, Kadar Marikar, Marc Mendelson, Pierre Parneix, Eli Perencevich, Hardeep Singh, Sarah Tschudin-Sutter, Shin Ushiro, Evelyn Wesangula, Céline Gardiol, Gerald Dziekan, Stephan Harbarth, Didier Pittet

     
• • ·Revisiting the minimum incubation period of Zaire ebolavirus

    Page :1111-1112

    Aaron D Kofman, Dana L Haberling, Gisele Mbuyi, Lise D Martel, Amy N Whitesell, Michel Van Herp, Gerry Makaya, Salomon Corvil, Aaron Aruna Abedi, Patrick Mavungu Ngoma, Francis Mbuyi, Mathias Mossoko, Enogo Koivogui, Norbert Soke, Nouonan Gbamou, Peter N Fonjungo, Lamine Keita, Sakoba Keita, Trevor R Shoemaker, Guy A Richards, Joel M Montgomery, Joel G Breman, Thomas W Geisbert, Mary J Choi, Pierre E Rollin

      
• • ·Clean Hospitals Day 2023 and the launch of an environmental-hygiene self-assessment tool

    Page :e390

    Alexandra Peters, Pierre Parneix, Didier Pittet, Clean Hospitals

     
• • ·Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3

    Page :e391

    Lu Zhang, Amy Kempf, Inga Nehlmeier, Anne Cossmann, Alexandra Dopfer-Jablonka, Metodi V Stankov, Sebastian R Schulz, Hans-Martin Jäck, Georg M N Behrens, Stefan Pöhlmann, Markus Hoffmann

     
• • ·SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters

    Page :e393

    Kim Blom, Peter Fjällström, Christian Molnár, Mikael Åberg, Linnea Vikström, Julia Wigren-Byström, Louise Bennet, Micael Widerström, Gunlög Rasmussen, Jonas Klingström, Mattias N E Forsell, Anders F Johansson

      
• • ·Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5

    Page :e395

    Yu Kaku, Yusuke Kosugi, Keiya Uriu, Jumpei Ito, Alfredo A Hinay, Jin Kuramochi, Kenji Sadamasu, Kazuhisa Yoshimura, Hiroyuki Asakura, Mami Nagashima, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato

     
• • ·Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6

    Page :e397

    Qian Wang, Yicheng Guo, Richard M Zhang, Jerren Ho, Hiroshi Mohri, Riccardo Valdez, David M Manthei, Aubree Gordon, Lihong Liu, David D Ho

     
• • ·Molecular-viability testing and antimicrobial resistance in sexually transmitted infections

    Page :e399

    Wilhelmina M Huston

    
• • ·Correction to Lancet Infect Dis 2022; 22: 1293–302

    Page :e400

    
• • ·Correction to Lancet Infect Dis 2022; 22: 64–72

    Page :e400

    
• • ·Correction to Lancet Infect Dis 2023; published online June 8. https://doi.org/10.1016/S1473-3099(23)00299-2

    Page :e400

    
• • ·Correction to Lancet Infect Dis 2023; published online Aug 3. https://doi.org/10.1016/S1473-3099(23)00344-4

    Page :e400

    
• • ·Correction to Lancet Infect Dis 2023; 23: 983

    Page :e400

    
• • ·Locally acquired malaria cases in the USA

    Page :e401

    Sanjeet Bagcchi

     
• • ·First treatment approved for molluscum contagiosum

    Page :e402

    Priya Venkatesan

     
• • ·Mobile laboratory donations to African countries

    Page :e403

    Esther Nakkazi

     
• • ·Iraq eliminates trachoma as a public health problem

    Page :e404

    Vijay Shankar Balakrishnan

    
• • ·Scabies: the neglected tropical disease that is everywhere

    Page :e405

    Talha Burki

     
• • ·Infectious diseases surveillance update

    Page :e407

    Ruth Zwizwai

    Plan Plan
• • ·Research in brief

    Page :e408

    Sharmila Devi

    Plan Plan
• • ·Gerald Lee “Jerry” Mandell

    Page :1113

    Sanjeet Bagcchi

     
• • ·Neena Valecha—stepping up malaria elimination efforts in southeast Asia

    Page :1114

    Tony Kirby

     
• • ·A holistic approach to HIV management

    Page :1115

    Phoebe Ashley-Norman

     
• • ·A fatal jump: not if, but when

    Page :1116

    Jessica Pope

     
• • ·The birth of intensive care units

    Page :1117

    Marco Conforti

     
• • ·Environment and infectious diseases

    Page :1118

    Talha Burki

     
• • ·Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

    Page :1119-1129

    Carolyn T Bramante, John B Buse, David M Liebovitz, Jacinda M Nicklas, Michael A Puskarich, Ken Cohen, Hrishikesh K Belani, Blake J Anderson, Jared D Huling, Christopher J Tignanelli, Jennifer L Thompson, Matthew Pullen, Esteban Lemus Wirtz, Lianne K Siegel, Jennifer L Proper, David J Odde, Nichole R Klatt, Nancy E Sherwood, Sarah M Lindberg, Amy B Karger, Kenneth B Beckman, Spencer M Erickson, Sarah L Fenno, Katrina M Hartman, Michael R Rose, Tanvi Mehta, Barkha Patel, Gwendolyn Griffiths, Neeta S Bhat, Thomas A Murray, David R Boulware, the COVID-OUT Study Team, Blake Anderson, Riannon C Atwater, Nandini Avula, Kenny B Beckman, Hrishikesh K Belani, David R Boulware, Carolyn T Bramante, Jannis Brea, Courtney A Broedlow, John B Buse, Paula Campora, Anup Challa, Jill Charles, Grace Christensen, Theresa Christiansen, Ken Cohen, Bo Connelly, Srijani Datta, Nikita Deng, Alex T Dunn, Spencer M Erickson, Faith M Fairbairn, Sarah L Fenno, Daniel J Fraser, Regina D Fricton, Gwen Griffiths, Aubrey A Hagen, Katrina M Hartman, Audrey F Hendrickson, Jared D Huling, Nicholas E Ingraham, Arthur C Jeng, Darrell M Johnson, Amy B Karger, Nichole R Klatt, Erik A Kuehl, Derek D LaBar, Samuel Lee, David M Liebovitz, Sarah Lindberg, Darlette G Luke, Rosario Machicado, Zeinab Mohamud, Thomas A Murray, Rumbidzai Ngonyama, Jacinda M Nicklas, David J Odde, Elliott Parrens, Daniela Parra, Barkha Patel, Jennifer L Proper, Matthew F Pullen, Michael A Puskarich, Via Rao, Neha V Reddy, Naveen Reddy, Katelyn J Rypka, Hanna G Saveraid, Paula Seloadji, Arman Shahriar, Nancy Sherwood, Jamie L Siegart, Lianne K Siegel, Lucas Simmons, Isabella Sinelli, Palak Singh, Andrew Snyder, Maxwell T Stauffer, Jennifer Thompson, Christopher J Tignanelli, Tannon L Tople, Walker J Tordsen, Ray HB Watson, Beiqing Wu, Adnin Zaman, Madeline R Zolik, Lena Zinkl

    Résumé Résumé Plan Plan   
• • ·Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study

    Page :1130-1142

    Dan Yamin, Matan Yechezkel, Ronen Arbel, Tanya Beckenstein, Ruslan Sergienko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Doron Netzer, Erez Shmueli

    Résumé Résumé Plan Plan   
• • ·Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

    Page :1143-1152

    Jing-Xin Li, Li-Hua Hou, Jin-Bo Gou, Zun-Dong Yin, Shi-Po Wu, Fu-Zhen Wang, Zhe Zhang, Zhi-Hang Peng, Tao Zhu, Hong-Bing Shen, Wei Chen, Feng-Cai Zhu, Six-Province COVID-19 Vaccine Study Group, Si-Yue Jia, Rong Tang, Hong-Xing Pan, Li Zhang, Jia-Wei Xu, Ji-Hai Tang, Qing Wang, Qing Xu, Yan Zheng, Tao Huang, Tao Li, Shu-Jun Liu, Cang-Ning Wang

    Résumé Résumé Plan Plan   
• • ·Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study

    Page :1153-1163

    Inge Sutanto, Amin Soebandrio, Lenny L Ekawati, Krisin Chand, Rintis Noviyanti, Ari Winasti Satyagraha, Decy Subekti, Yulia Widya Santy, Chelzie Crenna-Darusallam, Instiaty Instiaty, Waras Budiman, Catur Bidik Prasetya, Soroy Lardo, Iqbal Elyazar, Stephan Duparc, Eve Cedar, Katie Rolfe, Disala Fernando, Alessandro Berni, Siôn Jones, Jörg-Peter Kleim, Kim Fletcher, Hema Sharma, Ana Martin, Maxine Taylor, Navin Goyal, Justin A Green, Lionel K Tan, J Kevin Baird

    Résumé Résumé Plan Plan   
• • ·Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands

    Page :1164-1174

    Johan L van der Plas, Vincent P Kuiper, Wilhelmina M Bagchus, Matthias Bödding, Özkan Yalkinoglu, Aliona Tappert, Andrea Seitzinger, Thomas Spangenberg, Deon Bezuidenhout, Justin Wilkins, Claude Oeuvray, Satish K Dhingra, Vandana Thathy, David A Fidock, Lisanne C A Smidt, Geert V T Roozen, Jan Pieter R Koopman, Olivia A C Lamers, Jeroen Sijtsma, Roos van Schuijlenburg, Els Wessels, Pauline Meij, Ingrid M C Kamerling, Meta Roestenberg, Akash Khandelwal

    Résumé Résumé Plan Plan   
• • ·Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

    Page :1175-1185

    Michael A Koren, Leyi Lin, Kenneth H Eckels, Rafael De La Barrera, Vincent Dussupt, Gina Donofrio, Erica L Sondergaard, Kristin T Mills, Merlin L Robb, Christine Lee, Oluwaseun Adedeji, Paul B Keiser, Justin M Curley, Nathanial K Copeland, Trevor A Crowell, Jack N Hutter, Melinda J Hamer, Anais Valencia-Ruiz, Janice Darden, Sheila Peel, Mihret F Amare, Tsedal Mebrahtu, Margaret Costanzo, Shelly J Krebs, Gregory D Gromowski, Richard G Jarman, Stephen J Thomas, Nelson L Michael, Kayvon Modjarrad

    Résumé Résumé Plan Plan   
• • ·Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

    Page :1186-1196

    Nicole Bézay, Romana Hochreiter, Vera Kadlecek, Nina Wressnigg, Julian Larcher-Senn, Anton Klingler, Katrin Dubischar, Susanne Eder-Lingelbach, Isabel Leroux-Roels, Geert Leroux-Roels, Wolfgang Bender

    Résumé Résumé Plan Plan   
• • ·Trends in invasive Haemophilus influenzae serotype a disease in England from 2008–09 to 2021–22: a prospective national surveillance study

    Page :1197-1206

    Marta Bertran, Joshua C D’Aeth, Erjola Hani, Zahin Amin-Chowdhury, Norman K Fry, Mary E Ramsay, David J Litt, Shamez N Ladhani

    Résumé Résumé Plan Plan   
• • ·Super-spreaders: a historical review

    Page :e409

    Amir Teicher

    Résumé Résumé Plan Plan  
• • ·A partner protection package for HIV cure-related trials involving analytical treatment interruptions

    Page :e418

    Karine Dubé, Tia Morton, Lawrence Fox, Lynda Dee, David Palm, Thomas J Villa, William Freshwater, Jeff Taylor, Gail Graham, William B Carter, John A Sauceda, Michael J Peluso, Annette Rid

    Résumé Résumé Plan Plan  
• • ·Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future

    Page :e431

    Naomi R Lee, Alexandra King, Deionna Vigil, Dustin Mullaney, Priscilla R Sanderson, Taiwo Ametepee, Laura L Hammitt

    Résumé Résumé Plan Plan  
• • ·A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection

    Page :e445

    Noé Brasier, H Ceren Ates, Juliane R Sempionatto, Menino O Cotta, Andreas F Widmer, Jens Eckstein, Jörg Goldhahn, Jason A Roberts, Wei Gao, Can Dincer

    Résumé Résumé Plan Plan  
• • ·Pulmonary paragonimiasis in a child with chronic recurrent wet cough

    Page :e454

    Wonashi R Tsanglao, Sungkumtangla Jamir